RCD news
The Blue Box closes a funding round for the regulatory approval of its innovative medical device for breast cancer detection
The Blue Box Biomedical Solutions, a start-up that develops an innovative medical device that detects breast cancer from a urine sample using artificial intelligence, has closed a funding round
The new funds will enable the company to advance to the clinical trial phase in Europe and obtain CE marking before the end of 2026. In addition, this funding represents a clear validation of the scientific and technical work behind its revolutionary technology and a decisive step towards simpler, more accessible, and non-invasive early detection of breast cancer.
A team led by Ramon Manyà advised The Blue Box on this transaction.
